| 000 | 01220 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514201641.0 | ||
| 264 | 0 | _c20041108 | |
| 008 | 200411s 0 0 eng d | ||
| 022 | _a0025-729X | ||
| 024 | 7 |
_a10.5694/j.1326-5377.2004.tb06307.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFenn, Chris G | |
| 245 | 0 | 0 |
_aCost-effectiveness findings not based on available evidence. _h[electronic resource] |
| 260 |
_bThe Medical journal of Australia _cSep 2004 |
||
| 300 |
_a339; author reply 339-40 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Comparative Study; Letter | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 | _aDrug Industry |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 773 | 0 |
_tThe Medical journal of Australia _gvol. 181 _gno. 6 _gp. 339; author reply 339-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5694/j.1326-5377.2004.tb06307.x _zAvailable from publisher's website |
| 999 |
_c15070610 _d15070610 |
||